[ET Net News Agency, 17 January 2025] Morgan Stanley lowered the target price for Trad
Chi Med (00570) to HKD1.7 from HKD2.6 and downgraded the rating to "underweight" from
"equal-weight".
The research house said it cuts 2024 earnings by 80% and 2025-2030 earnings by 22% to
34%, factoring in lower formula granule sales and gross margins. (rc)